Harvard Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Advances in the Treatment of Lung Cancer
Pasi A Jnne, MD, Director, Lowe Center for Thoracic Oncology, Belfer Center for Applied Cancer Science, Senior Physician, Professor of Medicine at Harvard Medical School outlines an overview of the a... Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

How to Manage MDS Patients who are Ineligible for Transplant
Daniel DeAngelo MD, Institute Physician, Professor of Medicine at Harvard Medical School comments on how myelodysplastic syndrome (MDS) patients who are ineligible for transplants can be managed. Author: obr Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 26, 2019 Category: Cancer & Oncology Source Type: podcasts

The Recent Wave of Approval in AML
Daniel DeAngelo MD, Institute Physician, Professor of Medicine at Harvard Medical School discusses the recent wave of approvals in AML and how it has changed treatment planning for patients. Author: obr Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 26, 2019 Category: Cancer & Oncology Source Type: podcasts

Updated Data on Gilteritinib in AML
Daniel DeAngelo MD, Institute Physician, Professor of Medicine at Harvard Medical School comments on the importance of the updated data on gilteritinib in acute myeloid leukemia (AML). Author: obr Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 26, 2019 Category: Cancer & Oncology Source Type: podcasts

Latest Data on Uproleselan with Chemotherapy
Daniel DeAngelo MD, Institute Physician, Professor of Medicine at Harvard Medical School elaborates on the phase III study of uproleselan with chemotherapy in patients with relapsed acute myeloid leuk... Author: obr Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 26, 2019 Category: Cancer & Oncology Source Type: podcasts

Next Steps if Patient Fails 1st Line Therapy in HCC with Immunocology
Thomas A. Abrams Senior Physician and Assistant Professor of Medicine at Harvard Medical School explains the next steps a patient with hepatocellular carcinoma (HCC) can do if they fail the 1st line t... Author: obr Added: 06/25/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 25, 2019 Category: Cancer & Oncology Source Type: podcasts

KEYNOTE-062: Pembrolizumab in HER2-, PD-L1 Positive Advanced Gastric Cancer
Thomas A. Abrams Senior Physician and Assistant Professor of Medicine at Harvard Medical School tells us his thoughts on KEYNOTE-62. This is investigating pembrolizumab in HER2, PD-L1 positive advanc... Author: obr Added: 06/25/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 25, 2019 Category: Cancer & Oncology Source Type: podcasts

Results of the APACT Study: Phase III Trial of Adjuvant Nab-Paclitaxel
Thomas A. Abrams, Senior Physician and Assistant Medical Professor at Harvard Medical School provides results about the APACT Study. APACT Study is a phase III trial of adjuvant nab-paclitaxel plus ... Author: obr Added: 06/25/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 25, 2019 Category: Cancer & Oncology Source Type: podcasts

POLO Trial with Olaparib in Metastatic Pancreatic Cancer
Dr. Thomas A. Abrams, Senior Physician and Assistant Professor of Medicine at Harvard Medical School discusses whether the POLO Trial with olaparib in metastatic pancreatic cancer is practice changing... Author: obr Added: 06/25/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 25, 2019 Category: Cancer & Oncology Source Type: podcasts

Bringing Primary Physician Back Into The Care Of Patients With Cancer: Not All Primary Care Physicians Feel Comfortable Or Would Like To Engage With Their Patients While They Are Getting Cancer Care
Larissa Nekhlyudov MD MPH Of Brigham & Womens Hospital/Dana-Farber Cancer Institute, Harvard Medical School Discusses Bringing Primary Physician Back Into The Care Of Patients With Cancer: Not All Pr... Author: Annual-Meeting Added: 06/12/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 13, 2019 Category: Cancer & Oncology Source Type: podcasts

Need To Optimize Communication & Care Coordination: Sexual Health Is Important & Doctors Need To Ask Questions About It, Electronic Health Records Have Potential To Improve Communication
Larissa Nekhlyudov MD MPH Of Brigham & Womens Hospital/Dana-Farber Cancer Institute, Harvard Medical School Discusses Need To Optimize Communication & Care Coordination: Sexual Health Is Important & ... Author: Annual-Meeting Added: 06/12/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 13, 2019 Category: Cancer & Oncology Source Type: podcasts

The Process Of Tumor Genesis & Tumor Cells Response To Therapy: Its Predicted That If You Could Target Stress Relief Programs You Might Get Much More Efficient Therapy
Joan Brugge PhD Of Harvard Medical School Discusses The Process Of Tumor Genesis & Tumor Cells Response To Therapy: Its Predicted That If You Could Target Stress Relief Programs You Might Get Much Mor... Author: Annual-Meeting Added: 06/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Whether Regorafenib Is Becoming More Tolerable For mCRC Patients
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, Whether Regorafenib Is Becoming More Tolerable Fo... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Genetic Testing In Newly Diagnosed mCRC
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, Genetic Testing In Newly Diagnosed mCRC. At The 2... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Thoughts On Checkpoint Inhibitors In Adjuvant CRC
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, Thoughts On Checkpoint Inhibitors In Adjuvant CRC... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts